0001493152-26-019663
SEC filingThis 10-K/A amendment supplies omitted Part III governance disclosures on directors, executives, compensation structures, ownership, related transactions, and audit fees, driven by a delayed 2026 proxy statement beyond the 120-day post-fiscal year-end deadline. It prioritizes regulatory compliance without altering financial statements or metrics.
This 10-K/A, filed April 29, 2026, amends the original 10-K exclusively to provide Part III disclosures omitted due to the 2026 proxy statement's delay past 120 days after fiscal year-end. By addressing directors, executive officers, compensation, security ownership of certain beneficial owners and management, related party transactions, and principal accountant fees, the filing ensures full compliance with SEC requirements amid proxy preparation challenges, allowing investors to assess leadership accountability and alignment without new financial data.
The amendment details board composition and executive roles, highlighting transitions that adapt to the company's strategic needs. These changes underscore a focus on specialized expertise in medical leadership and finance, positioning the team to navigate ongoing operational demands. Such alignment supports sustained oversight during periods of capital dependency and external consulting reliance, fostering resilience in governance structures.
Compensation disclosures reveal structures designed for cash efficiency, emphasizing equity incentives over salary to conserve liquidity. This approach reflects deliberate strategies to retain key talent amid lean operations, balancing immediate financial prudence with long-term motivation through performance-tied rewards. Investors benefit from transparency into how pay aligns executive interests with shareholder value creation in a resource-constrained environment.
Details on equity incentive plans illustrate efforts to secure a compact workforce via share-based retention tools. By expanding available shares under existing plans, the company addresses motivation for a limited employee and contractor base, critical for maintaining expertise without heavy cash outlays. This mechanism signals confidence in future growth potential, tying personnel stability to equity upside.
Ownership and related-party transaction sections disclose affiliate involvements, explaining capital sourcing from connected entities. These infusions highlight network leverage to fund operations, providing visibility into interests held by leadership and their role in sustaining activities. Such reliance underscores strategic relationships that bridge funding gaps, with disclosures ensuring scrutiny of potential conflicts.
Principal accountant fees and services outline audit continuity despite firm transitions, affirming rigorous financial oversight. This stability reassures stakeholders of independent validation processes, essential for credibility in governance-focused amendments. The emphasis on audit matters reflects proactive compliance, mitigating risks from delayed filings and supporting trust in reported controls.